Stock Price

InTest Corp's inclusion in the Russell 2000/3000 is more than a ticker change. It's a validation of a growth strategy in critical tech sectors.

The community-owned retailer gains institutional visibility with its Russell 3000 inclusion, but staggering losses and a volatile past paint a complex picture.

DeFi Development Corp. splits from its UK affiliate, now Cykel AI, signaling a major trend: radical specialization in the volatile crypto and AI markets.

A shareholder revolt at Solmate Infrastructure exposes deep governance rifts, as a board's re-election hinges on votes from a controversial share deal.

A $49M government-backed loan sends a Connecticut company’s stock soaring. Is this the future of American clean energy or a risky taxpayer-funded gamble?

Activist investor SilverCape issues a stark ultimatum to PetMed Express, cutting its takeover bid from $4 to $3, blaming board inaction for value destruction.

The AI-battery pioneer's inclusion in a major index brings institutional visibility, but a deep dive reveals a classic growth-versus-profitability story.

Kite Realty Group's $300M note offering isn't just about debt. It's a masterclass in capital strategy, shareholder protection, and Sun Belt growth.

Farmmi Inc.'s $3M offering sent its stock plummeting 69%. Is this a desperate move for survival or a strategic play to fund its ambitious U.S. expansion?

A massive $255M penalty and a class-action lawsuit reveal the high-stakes risks for Futu Holdings, a cautionary tale of cross-border fintech compliance.

Futu Holdings faces a $271M penalty and a class-action lawsuit. We dissect the operational missteps and the broader risks for cross-border fintech.

A small Shanghai tech firm just raised $1.5M to fund its AI pivot. Is this a savvy move for survival or a drop in the ocean of a global tech arms race?

Orion S.A.'s minor dividend hike projects stability, but a look at recent financials and market trends reveals a more complex picture for the carbon black giant.

The NYSE delisted Lanvin Group's warrants, citing an 'abnormally low price.' This move highlights the exchange's tougher stance and raises questions about the luxury firm.

uniQure's upsized $259M offering signals massive investor confidence, fueling its Huntington's therapy, AMT-130, and reshaping the gene therapy landscape.

With court approval secured, First Capital's $9.4B sale to KingSett and Choice Properties is nearly complete, signaling a major consolidation in Canada's prized grocery-anchored real estate market.

After a blockbuster NYSE debut, a deep dive into how manufacturer Doncasters will use $1B to pay down debt and dominate the high-tech components market.

The high court's 7-2 decision on Roundup not only ends a legal saga for Bayer but signals a major shift in product liability across all federally regulated industries.

Healthcare tech firm Phreesia faces a securities fraud lawsuit alleging it misled investors on growth, casting doubt on its Network Solutions segment.

SUI Group's expanded loan to Bluefin isn't just a deal; it's a strategic maneuver to consolidate Sui's DeFi landscape and forge a new model for institutional investment.